Skip to content
value.today

NeuroPace, Inc. vs Sight Sciences, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • NeuroPace, Inc. is the larger company by market value: $487 M against $448 M for Sight Sciences, Inc., 1.1 times as much (market caps of Sep 18, 2026 for NeuroPace, Inc. and Aug 1, 2026 for Sight Sciences, Inc.). NeuroPace, Inc.'s value is the last on file, from Sep 18, 2026: no market-data feed is connected for its exchange yet. Sight Sciences, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
  • NeuroPace, Inc. had more revenue: $100 M against $77 M for Sight Sciences, Inc., both in the year to December 2025.
  • Both made a net loss: $21 M for NeuroPace, Inc. and $38 M for Sight Sciences, Inc.
  • NeuroPace, Inc. keeps more of each dollar of sales: a net margin of -21.5% against -49.7% for Sight Sciences, Inc.
  • NeuroPace, Inc. employs more people: 209 against 186 at Sight Sciences, Inc. Each employee brings in about $478,421 of revenue at NeuroPace, Inc. and $415,914 at Sight Sciences, Inc.
  • NeuroPace, Inc.'s revenue grew faster in its latest fiscal year: +25.1% against -3.1% for Sight Sciences, Inc.
  • On the Piotroski F-score, a nine-point test of improving finances, NeuroPace, Inc. scores 5 and Sight Sciences, Inc. 5. Both are in the distress zone of the Altman Z-score.

Market value, the same start = 100

From Jan 2022: how each one's value moved, whatever its size.

0521041562082023202420252026NeuroPace, Inc. 200Sight Sciences, Inc. 60

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B20212022202320242025NeuroPace, Inc. $0BSight Sciences, Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureNeuroPace, Inc.
NPCE · #12,651 in the world
Sight Sciences, Inc.
SGHT · #13,037 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryMedical DevicesMedical Devices
Founded19972010
Size
Market cap$487 M$448 M
Revenue$100 M$77 M
Net income$-21 M▲ best$-38 M
Employees209186
Valuation
Price to sales4.8×5.1×
Price to book25.6×7.0×
Free cash flow yield-2.3%▲ best-6.7%
Profitability
Gross margin77.2%86.2%▲ best
Operating margin-16.3%▲ best-48.0%
Net margin-21.5%▲ best-49.7%
Return on equity-158.7%-50.8%▲ best
Growth
Revenue growth25.1%▲ best-3.1%
Revenue growth, 3 years a year30.0%▲ best2.7%
Financial strength
Debt to equity3.1×0.7×▲ best
Interest cover—-7.2×
Cash
Free cash flow margin-11.3%▲ best-38.7%
Shareholder returns
Shareholder yield10.2%—
Strength scores
Piotroski F-score5 of 95 of 9▲ best
Altman Z-score zonedistressdistress
Data as ofMarket cap Sep 2026; ratios FY2025Market cap Aug 2026; ratios FY2025

Questions and answers#

Which is bigger, NeuroPace, Inc. or Sight Sciences, Inc.?

NeuroPace, Inc. is the larger company by market value: $487 M against $448 M for Sight Sciences, Inc., 1.1 times as much (market caps of Sep 18, 2026 for NeuroPace, Inc. and Aug 1, 2026 for Sight Sciences, Inc.). NeuroPace, Inc.'s value is the last on file, from Sep 18, 2026: no market-data feed is connected for its exchange yet. Sight Sciences, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.

Which makes more money, NeuroPace, Inc. or Sight Sciences, Inc.?

NeuroPace, Inc. had more revenue: $100 M against $77 M for Sight Sciences, Inc., both in the year to December 2025. Both made a net loss: $21 M for NeuroPace, Inc. and $38 M for Sight Sciences, Inc.

Which is more profitable, NeuroPace, Inc. or Sight Sciences, Inc.?

NeuroPace, Inc. keeps more of each dollar of sales: a net margin of -21.5% against -49.7% for Sight Sciences, Inc.

Which has more employees, NeuroPace, Inc. or Sight Sciences, Inc.?

NeuroPace, Inc. employs more people: 209 against 186 at Sight Sciences, Inc. Each employee brings in about $478,421 of revenue at NeuroPace, Inc. and $415,914 at Sight Sciences, Inc.

Which is growing faster, NeuroPace, Inc. or Sight Sciences, Inc.?

NeuroPace, Inc.'s revenue grew faster in its latest fiscal year: +25.1% against -3.1% for Sight Sciences, Inc.

Which is financially stronger, NeuroPace, Inc. or Sight Sciences, Inc.?

On the Piotroski F-score, a nine-point test of improving finances, NeuroPace, Inc. scores 5 and Sight Sciences, Inc. 5. Both are in the distress zone of the Altman Z-score.